Feb 19, 2026 04:35PM
Jan 12, 2026 08:04AM
Dec 17, 2025 04:04PM
Dec 17, 2025 05:02AM
Dec 1, 2025 12:33AM
Nov 5, 2025 07:29AM
Nov 4, 2025 05:50PM Spyre Therapeutics, Inc. (SYRE) Tops Q3 EPS by 62c
Oct 13, 2025 04:41PM
Oct 7, 2025 05:55AM
Sep 26, 2025 03:27AM
Aug 18, 2025 06:13AM
Aug 6, 2025 03:16AM
Jun 17, 2025 07:30AM
Jun 4, 2025 06:23AM Leerink Partners Reiterates Outperform Rating on Spyre (SYRE)
Jun 3, 2025 06:20AM
May 8, 2025 04:17PM
Mar 28, 2025 05:24AM
Mar 18, 2025 04:37AM
Mar 7, 2025 04:43PM
Feb 27, 2025 04:34PM
Feb 27, 2025 04:17PM Spyre Therapeutics, Inc. (SYRE) Tops Q4 EPS by 22c
Dec 3, 2024 06:36AM
Dec 2, 2024 08:10AM
Nov 18, 2024 04:14PM
Nov 12, 2024 12:50PM
Nov 12, 2024 07:30AM
Nov 7, 2024 04:21PM
Oct 25, 2024 06:08AM Spyre (SYRE) PT Raised to $65 at Guggenheim
Oct 17, 2024 06:50AM
Oct 15, 2024 06:18AM
Oct 15, 2024 05:58AM
Oct 14, 2024 02:18PM
Oct 14, 2024 08:01AM
Oct 1, 2024 08:02AM
Sep 25, 2024 06:41AM BTIG Reiterates Buy Rating on Spyre (SYRE)
Sep 20, 2024 04:09PM
Sep 6, 2024 04:13PM
Aug 8, 2024 04:06AM
Jul 18, 2024 08:06AM
Jul 16, 2024 07:02AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All